Granted Patent
B2
US 12,338,283 · App. 18/333,869 · Granted Jun 24, 2025
Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary fibrosis
Inventors:
Paul W. Noble (Beverly Hills, CA); Dianhua Jiang (Encion, CA); Carol Jiurong Liang (Encino, CA)
Assignee:
Cedars-Sinai Medical Center
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to methods for treating or preventing progressive pulmonary fibrosis in a subject.
Claims (21)
1. A method for reducing progression of progressive pulmonary fibrosis in a subject, the method comprising:
administering to the subject having idiopathic pulmonary fibrosis (IPF) a pharmaceutical composition comprising a therapeutic amount of a therapeutic agent targeting CD274 expressing cells in IPF lung fibroblasts,
wherein the subject has a higher level of total protein expression of PD-L1/CD274 in lung tissue, as compared to a control subject not suffering from pulmonary fibrosis, and
wherein the therapeutic agent comprises an inhibitor of programmed death receptor-ligand 1 (PD-L1) selected from the group consisting of atezolizumab, avelumab, durvalumab, MDX-1105, YW243.55.S70, and CA-170.
2. The method of claim 1 , wherein the method improves lung function in the subject.
3. The method of claim 1 , further comprising selecting the subject having IPF and a higher level of total protein expression of PD-L1/CD274 in lung tissue, as compared to a control subject not suffering from pulmonary fibrosis.
4. The method of claim 1 , further comprising selecting the subject having IPF and upregulation of PD-L1/CD274 and PD-L2/CD273 in invasive pulmonary fibroblasts, as compared to a control subject not suffering from pulmonary fibrosis.
5. The method of claim 1 , wherein the therapeutic agent is atezolizumab.
6. The method of claim 1 , wherein compared to an untreated control subject having IPF, the therapeutic amount modulates a programmed cell death pathway, and reduces progression of the progressive pulmonary fibrosis in the subject, and/or wherein compared to an untreated control subject having IPF, the therapeutic agent decreases the expression or biological activity of one or more of PD1, PD-L1, PD-L2, or RGMb in the subject.
7. The method of claim 1 , wherein the subject also has upregulation of PD1, PD-L1, PD-L2, or RGMb expression levels in lung tissue of the subject to which the pharmaceutical composition is to be administered, as compared to a control subject not suffering from pulmonary fibrosis.
8. The method of claim 1 , wherein the pharmaceutical composition further comprises a focal adhesion kinase (FAK) inhibitor in addition to the therapeutic agent.
9. The method of claim 1 , wherein the subject has upregulation of PD-L1/CD274 and PD-L2/CD273 in invasive pulmonary fibroblasts, as compared to a control subject not suffering from pulmonary fibrosis.
10. A method for reducing progression of progressive pulmonary fibrosis in a subject, the method comprising:
identifying a subject having idiopathic pulmonary fibrosis (IPF) for treatment for pulmonary fibrosis, lung tissue of the subject having a higher level of total protein expression of PD-L1/CD274, as compared to a control subject not suffering from pulmonary fibrosis;
selecting the subject having IPF; and
administering to the subject a pharmaceutical composition comprising a therapeutic amount of a therapeutic agent comprising atezolizumab.
11. The method of claim 10 , wherein the pharmaceutical composition further comprises a focal adhesion kinase (FAK) inhibitor in addition to the therapeutic agent.
12. The method of claim 10 , wherein elevated expression of RGMb is detected in the lung tissue of the subject, as compared to the control subject not suffering from pulmonary fibrosis.
13. The method of claim 10 , wherein upregulation of PD-L1/CD274 and PD-L2/CD273 is detected in invasive pulmonary fibroblasts of the subject, as compared to the control subject not suffering from pulmonary fibrosis.
14. The method of claim 10 , wherein compared to an untreated control subject having IPF, the therapeutic amount modulates a programmed cell death pathway, and reduces progression of the progressive pulmonary fibrosis in the subject, and/or wherein compared to an untreated control subject having IPF, the therapeutic agent decreases expression or biological activity of one or more of PD1, PD-L1, PD-L2, or RGMb in the subject.
15. The method of claim 1 , further comprising selecting the subject having IPF prior to administering the pharmaceutical composition.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 14, 2023
From: NOBLE, PAUL W.; JIANG, DIANHUA; LIANG, CAROL JIURONG
To: CEDARS-SINAI MEDICAL CENTER
Reel/Frame 063944/0711 →
Continuity (3)
Continuation
16652966
Provisional Application
62567513
· Oct 3, 2017
References Cited (400)
US 5010175A
· Rutter et al.
· 1991
[cited by applicant]
US 5288514A
· Ellman
· 1994
[cited by applicant]
US 5506337A
· Summerton et al.
· 1996
[cited by applicant]
US 5519134A
· Acevedo et al.
· 1996
[cited by applicant]
US 5525735A
· Gallop et al.
· 1996
[cited by applicant]
US 5539083A
· Cook et al.
· 1996
[cited by applicant]
US 5549974A
· Holmes
· 1996
[cited by applicant]
US 5569588A
· Ashby et al.
· 1996
[cited by applicant]
US 5582981A
· Toole et al.
· 1996
[cited by applicant]
US 5593853A
· Chen et al.
· 1997
[cited by applicant]
US 5595877A
· Gold et al.
· 1997
[cited by applicant]
US 5637459A
· Burke et al.
· 1997
[cited by applicant]
US 6133031A
· Monia et al.
· 2000
[cited by applicant]
US 20100184113A1
· Zhao et al.
· 2010
[cited by applicant]
US 20120159661A1
· Gimcher
· 2012
[cited by applicant]
US 20140093486A1
· Chiou et al.
· 2014
[cited by applicant]
US 20150258192A1
· Brophy et al.
· 2015
[cited by applicant]
US 20170275705A1
· Topalian et al.
· 2017
[cited by applicant]
EP 3352799A1
· 2018
[cited by applicant]
EP 3352792A1
· 2018
[cited by applicant]
EP 3352792B1
· 2020
[cited by applicant]
EP 3692073A1
· 2020
[cited by applicant]
WO 9119735A1
· 1991
[cited by applicant]
WO 9200091A1
· 1992
[cited by applicant]
WO 9320242A1
· 1993
[cited by applicant]
WO 2005112936A1
· 2005
[cited by applicant]
WO WO2015013508A2
· 2015
[cited by applicant]
WO 2016081475A1
· 2016
[cited by applicant]
WO 2016092082A1
· 2016
[cited by applicant]
WO WO2017051402A1
· 2017
[cited by applicant]
WO WO2017053952A1
· 2017
[cited by applicant]
WO WO2017053963A1
· 2017
[cited by applicant]
WO WO2019070908A1
· 2019
[cited by applicant]
Lee et al., Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1), J Exp Med. Sep. 17, 2001; 194(6): 809-21.
[cited by applicant]
Li and Jimenez, Protein kinase Cd and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitro, Arthritis Rheum. Aug. 2011; 63(8): 2473-83.
[cited by applicant]
Li Y et al., Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44, The Journal of experimental medicine. 2011 208(7):1459-71.
[cited by applicant]
Liang et al., Parallel synthesis and screening of a solid phase carbohydrate library, Science, 274:1520-1522 (1996).
[cited by applicant]
Liu et al., IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-β-independent Smad signaling, J Immunol. Sep. 1, 2011 ; 187(5): 2814-23.
[cited by applicant]
Liu et al., Inflammasome inhibitors: promising therapeutic approaches against cancer, J Exp Med. Aug. 2, 2010; 207(8) : 1 589-97.
[cited by applicant]
Loewe & Muischnek, 1926, Arch. Exp. Pathol Pharmacol. 114: 313-326 (Abstract Only).
[cited by applicant]
Lok, S.S. et al.Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice. Eur Respir J. Nov. 2002; 20(5): 1228-32.
[cited by applicant]
Lown, J.W., et al. The mechanism of the bleomycin-induced cleavage of DNA1. Biochem Biophys Res Commun. Aug. 22, 1977; 77(4): 1150-7.
[cited by applicant]
Mailleuix A A et al., Fgf10 expression identifies parabronchial smooth muscle cell progenitors and is required for their entry into the smooth muscle cell lineage, Development. May 2005; 132(9): 2157-66.
[cited by applicant]
Mason DP et al., Lung Transplantation for Idiopathic Pulmonary Fibrosis, Ann Thorac Surg 84:1121-8, 2007.
[cited by applicant]
Mason, RJ, Biology of alveolar type II cells Respirology, Jan. 2006; 11 Suppl: S12-5.
[cited by applicant]
McDonald, S. et al. Combined betaseron R (recombinant human interferon beta) and radiation for inoperable non- small cell lung cancer. Radiother Oncol. Mar. 1993; 26(3): 212-8.
[cited by applicant]
McLean GW, et al., The role of focal-adhesion kinase in cancer—a new therapeutic opportunity, Nat Rev Cancer. 2005;5(7):505-15.
[cited by applicant]
McQualter & Bertoncello, Consider Review: Deconstructing tje Lung to Reveal Its Regenerative Potential, Stem Cells. May 2012; 30(5): 811-6.
[cited by applicant]
McQualter et al., Endogenous Fibroblastic Progenitor Cells in the Adult Mouse Lung Are Highly Enriched in the Sca-1 Positive Cell Fraction, Stem Cells. 2009; 27: 61 2-22.
[cited by applicant]
McQualter, J.L., et al. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc Natl Acad Sci USA 2010; 107: 1414-19.
[cited by applicant]
Meltzer and Nobel, Idiopathetic pulmonary fibrosis, Orphanet J Rare Dis. Mar. 26, 2008; 3: 8. Doi: 10,1 186/1750-1 172-3-8.
[cited by applicant]
Mentink-Kane et al., Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Ra2, Gastroenterology. Dec. 2011; 141 (6): 2200-9.
[cited by applicant]
Mentink-Kane, M.M., et al. Opposing roles for IL-13 and IL-13 receptor a2 in health and disease. Immunol Rev. Dec. 2004; 202: 191-202.
[cited by applicant]
Miyazaki, Y. et al. Expression of a Tumor Necrosis Factor-a Transgene in Murine Lung Causes Lymphocytic and Fibrosing Alveolitis A Mouse Model of Progressive Pulmonary Fibrosis. J Clin Invest. Jul. 1995; 96(1): 250-9.
[cited by applicant]
Moore et al., Murine models of pulmonary fibrosis, Am J Physiol Lung Cell Mol Physiol. Feb. 2008; 294(2): L152-60.
[cited by applicant]
Moore, B.B. et al. Animal Models of Fibrotic Lung Disease. Am J Respir Cell Mol Biol. Aug. 2013; 49(2): 167-79.
[cited by applicant]
Moreno HB et al., Anti-programmed cell death protein-1/ligand-1 therapy in different cancers, Br J Cancer. 2015;112(9):1421-7.
[cited by applicant]
Morrisey E E & Hogan, Preparing for the first breath: genetic and cellular mechanisms in lung development, Dev Cell. Jan. 1 9, 2010; 18(1 ): 8-23.
[cited by applicant]
Muggia, F. et al., Pulmonary toxicity of antitumor agents, Cancer Treat Rev, 10: 221-243, 1983.
[cited by applicant]
Murray, L.A., et al. Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2. Int J Biochem Cell Biol. 2008; 40(10): 2174-82.
[cited by applicant]
Myers, J.L., et al. Epithelial Necrosis and Alveolar Collapse in the Pathogenesis of Usual Interstitial Pneumonia. Chest. Dec. 1988; 94(6): 1309-11.
[cited by applicant]
Needleman et al., A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol. Mar. 1970;48(3):443-53.
[cited by applicant]
Nguyen LT et al., and Clinical blockade of PD1 and LAG3-potential mechanisms of action. Nat Rev Immunol, 2015;15(1):45-56.
[cited by applicant]
Noble et al., Hyaluronan as an immune regulator in human diseases, Physiol Rev. Jan. 2011; 91 (1 ): 221-64.
[cited by applicant]
Noble P W et al., Idiopathic pulmonary fibrosis: new insights into pathogenesis, Clin Chest Med 25:749-758, 2004.
[cited by applicant]
Noble PW et al., Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials, Lancet. 2011;377(9779):1760-9.
[cited by applicant]
Noble PW et al., Pulmonary fibrosis: patterns and perpetrators, The Journal of clinical investigation. 2012;122(8):2756-62.
[cited by applicant]
Nuovo, G. J., The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis, (Molec.Pathol (2012) 25(3): 416-33.
[cited by applicant]
Osterreicher et al., Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the iver, Proc Natl Acad Sci USA. Nov. 23, 2010; 108(1 ): 308-13.
[cited by applicant]
Ostrand-Rosenberg S et al., The programmed death-1 immune-suppressive pathway: barrier to antitumor Immunity, J Immunol. 2014;193(8):3835-41.
[cited by applicant]
Parry RV, et al., CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms, Mol. Cell. Biol. 2005;25:9543-9553.
[cited by applicant]
Patsoukis N, et al., Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation, Sci Signal. 2012.
[cited by applicant]
Paulin, D., et al. Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle.Exp Cell Res. Nov. 15, 2004; 301(1): 1-7.
[cited by applicant]
PCT/US2018/54244; International Search Report and Written Opinion 5 pages, date of mailing Feb. 22, 2019.
[cited by applicant]
Pearson and Lipman, Improved tools for biological sequence comparison, Proc. Natl. Acad. Sci. 85:2444 (1988).
[cited by applicant]
Pearson W.R. (1994) Using the FASTA Program to Search Protein and DNA Sequence Databases. In: Griffin A.M., Griffin H.G. (eds) Computer Analysis of Sequence Data. Methods in Molecular Biology 24:307-331 1994 Humana Pres…
[cited by applicant]
Phan, S. et al., Bleomycin-induced pulmonary fibrosis in rats: biochemical demonstration of increased rate of collagen synthesis, Am Rev Respir Dis 121: 501-506, 1980.
[cited by applicant]
Phan, S. et al., Chest, A comparative study of pulmonary fibrosis induced by bleomycin and an 02 metabolite producing enzyme system, Chest., 83(5 Suppl): 44S-45S, 1983.
[cited by applicant]
Phillips, R.J., et al. Circulating fibrocytes traffic to the lungs in response to CXCL 12 and mediate fibrosis. J Clin Invest. Aug. 2004; 114(3): 438-46.
[cited by applicant]
Piguet et al., Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis, Am J Pahtol. Sep. 1993; 143(3): 651-5.
[cited by applicant]
Piguet, Tumor Necrosis Factor/Cachectin Plays a Key Role in Bleomycin-Induced Pneumopathy and Fibrosis. J. Exp Med, Sep. 1, 1989, vol. 170, No. 3, p. 655-663; abstract; p. 661, para 2.
[cited by applicant]
Prasse et al., Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med. Apr. 1 5, 2009; 179(8) : 717-23.
[cited by applicant]
Rafii et al., A review of current and novel therapies for idiopathic pulmonary fibrosis, J Thorac Dis. 2013; 5(1 ): 48-73.
[cited by applicant]
Raghu et al., Incidence and prevalence of idiopathic pulmonary fibrosis, Am J Respir Crit Care Med. Oct. 1, 2006 ; 174(7): 810-6.
[cited by applicant]
Ramalingam et al., Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain, Nat Immunol. Jan. 2008; 9(1 ): 25-33.
[cited by applicant]
Ramasamy S K et al., Fgf10 dosage is critical for the amplification of epithelial cell progenitors and for the formation of multiple mesenchymal lineages during lung development, Dev Biol. Jul. 15, 2007; 307(2): 237-47.
[cited by applicant]
Ramirez et al., Myofibroblast transdifferentiation in obliterative bronchiolitis: tgf-beta signaling through smad3-dependent and -independent pathways, Am J Transplant. Sep. 2006; 6(9): 2080-8.
[cited by applicant]
Ramos et al., Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and issue inhibitor of metalloproteinases expression, Am J Respir Cell Mol Biol. May 2001; 24(5): 591-8.
[cited by applicant]
Richeldi L et al., Corticosteroids for idiopathic pulmonary fibrosis, The Cochrane database of systematic reviews. 20033):CD002880.
[cited by applicant]
Riise et al., Bronchial brush biopsies for studies of epithelial inflammation in stable asthma and nonobstructive chronic bronchitis, (1992) Eur Resp J 5:382.
[cited by applicant]
Riise et al., Bronchial brush biopsies for studies of epithelial inflammation in stable asthma and nonobstructive chronic bronchitis, (1996) Eur Resp J 9:1665.
[cited by applicant]
Rock, J.R., et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA. Dec. 27, 2011; 108(52): E1475-83.
[cited by applicant]
Romer LH, et al., Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells, Mol Biol Cell. 1994;5(3):349-61.
[cited by applicant]
Rothman, B. L. et al., Cytokine regulation of C3 and C5 production by the human type II pneumocyte cell line, A549, J Immunol. 1990; 145: 592-598.
[cited by applicant]
Satelli & Li., Vimentin in cancer and its potential as a molecular target for cancer therapy, Cell Mol Life Sci. Sep. 2011; 68(18): 3033-46.
[cited by applicant]
Satoh et al., Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases, J Intern Med. Nov. 2006; 260(5): 429-34.
[cited by applicant]
Sausville, E., et al. A role for ferrous ion and oxygen in the degradation of DNA by bleomycin. Biochem Biophys Res Commun. Dec. 6, 1976; 73(3): 814-22.
[cited by applicant]
Schniedermann et al., Mouse lung contains endothelial progenitors with high capacity to form blood and lymphatic vessels, Cell Biol. 2010; 11 :50.
[cited by applicant]
Schrier D. et al., The Role of Strain Variation in Murine Bleomycin-Induced Pulmonary Fibrosis. Am Rev Respir Dis., 127(1):63-6,1983.
[cited by applicant]
Selman M et al., Emerging drugs for idiopathic pulmonary fibrosis, Expert Opin Emerg Drugs 16:341-62, 2011.
[cited by applicant]
Selman M et al., Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy, Ann Intern Med 134:136-151, 2001.
[cited by applicant]
Shan L et al., Centrifugal migration of mesenchymal cells in embryonic lung, Dev Dyn. 2008; 237: 750-5.
[cited by applicant]
Shannon & Deterding, Epithelial-mesenchymal interactions in lung development. In: McDonald JA, ed. Lung Biology in Health and Disease. vol. 100. New York: Marcel Dekker Inc., 1997, pp. 81-118.
[cited by applicant]
Shannon, JM. and Deterding RR. Epithelial-mesenchymal interactions in lung development. In: Lung Growth and Development, (ed. JA McDonald) vol. 100, New York: Marcel Dekker Inc, 1997, pp. 81-118.
[cited by applicant]
Sheppard KA, et al., PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta, FEBS Lett. 2004;574:37-41.
[cited by applicant]
Shetty S et al., Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs, Am J Respir Cell Mol Biol 15:78-87, 1996.
[cited by applicant]
Shibata K, et al., Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells, Cancer Res. 1998;58(5):900-3.
[cited by applicant]
Smith et al., Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease, J Clin Pathol. Oct. 2013; 66(1 ): 896-903.
[cited by applicant]
Snider, G. et al., Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied, Am Rev Respir D…
[cited by applicant]
Song et al., Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome, Eur Respir J. Feb. 2011; 37(2): 356-63.
[cited by applicant]
Starcher, B. et al., Increased elastin and collagen content in the lungs of hamsters receiving an intratracheal injection of bleomycin, Am Rev Respir Dis., 117(2): 299-305, 1978.
[cited by applicant]
Staron MM, et al., The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection, Immunity. 2014;41:802-814.
[cited by applicant]
Strieter RM et al., The role of CXC chemokines in pulmonary fibrosis, The Journal of clinical investigation. 2007;117(3):549-56.
[cited by applicant]
Strunk, R. C. et al., Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways, Clin Invest. 1988; 81 : 1419-1426.
[cited by applicant]
Suganuma, H et al., Enhanced migration of fibroblasts derived from lungs with fibrotic lesions. Thorax 50:984-9, 1995.
[cited by applicant]
Summer et al., Isolation of an Adult Mouse Lung Mesenchymal Progenitor Cell Population, Am J Respir Cell Mol Biol. 2007; 37: 152-9.
[cited by applicant]
Tanjore et al., Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis, Am J Respir Crit Care Med. Oct. 1, 2009 ; 180(7): 657-65.
[cited by applicant]
Thannickal et al., J Biol Chem . Apr. 4, 2003;278(14):12384-9. doi: 10.1074/jbc.M208544200. Epub Jan. 16, 2003. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integri…
[cited by applicant]
Thebaud & Yoder. Pulmonary endothelial progenitor cells. In: Voelkel NF, Rounds S, eds. The Pulmonary Endothelium: Function in Health and Disease. Chichester, West Sussex: Wiley, 2009: 203-16.
[cited by applicant]
Thrall, R. et al., Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am J Pathol, 95: 117-130, 1979.
[cited by applicant]
Timmermans et al., Endothelial progentior cells: identity defined?, J Cell Mol Med. 2009; 13: 87-102.
[cited by applicant]
Tomasek et al., Myofroblasts and mechano-regulation of connective tissue remodelling, Nat Rev Mol Cell Biol. May 2002; 3(5): 349-63.
[cited by applicant]
Toole, B. P. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. Jul. 2004; 4(7): 528-39.
[cited by applicant]
Torry et al, Anchorage-independent colony growth of pulmonary fibroblasts derived from fibrotic human lung tissue, J Clin Invest. Apr. 1994; 93(4): 1525-32.
[cited by applicant]
Umezawa, H. et al., Studies on bleomycin, Cancer 20: 891-895, 1967.
[cited by applicant]
Umezawa, H., Chemistry and mechanism of action of bleomycin, Fed Proc, 33: 2296-2302, 1974.
[cited by applicant]
Vaughn et al., Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library, Nature Biotechnology, 14(3):309-314 (1996).
[cited by applicant]
Vittal R. et al., Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: Implications for treatment of fibrotic diseases, J Pharmacol Exp Ther., 321(1): 35-44, 2007.
[cited by applicant]
Vittal, R. et al., Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury, Am J Pathol., 166(2): 367-75, 2005.
[cited by applicant]
Voelkel NF, Rounds S, eds. The Pulmonary Endothelium: Function in Health and Disease. Chichester, West Suxssex: Wiley-Blackwell, 2009: 51-72.
[cited by applicant]
Volckaert et al., Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury, J Clin Invest. 2011 ; 121 : 4409-19.
[cited by applicant]
Waghray et al., Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts, FASEB J. May 2005; 19(7): 854-6.
[cited by applicant]
Wang et al., A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells, Proc Natl Acad Sci USA. Mar. 13, 2007; 104(11 ): 4449-54.
[cited by applicant]
Dong et al., B7-H1 pathway and its role in the evasion of tumor immunity, (2003) J. Mol. Med. 81:281-7.
[cited by applicant]
Dong H et al., Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8(8):793-800.
[cited by applicant]
Dong Y et al., Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice. The Journal of experimental medicine. 2015;212(2):235-52.
[cited by applicant]
Dr, Noble, Kumar et al., Let-7 micro RNA-mediation regulation of IL-13 and allergic airway inflammation, J. Allergy Clin. Immunol. 128:1077-85 (2011).
[cited by applicant]
Du Bois, RM. Strategies for treating idiopathic pulmonary fibrosis. Nature reviews Drug discovery. 2010;9(2):129-40.
[cited by applicant]
Dulauroy, S. et al. Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med. Aug. 2012; 18(8): 1262-70.
[cited by applicant]
Duong, H., et al. Pro-angiogenic Hematopoietic Progenitor Cells and Endothelial Colony Forming Cells in Pathological Angiogenesis of Bronchial and Pulmonary Circulation. Angiogenesis. 2011; 14(4): 411-22.
[cited by applicant]
Fala, L. et al., (2015), Ofev (Nintedanib): First Tyrosine Kinase Inhibitor Approved for the Treatment of Patients with Idiopathic Pulmonary Fibrosis, Am. Health Drug benefits 8 (Spec. Features): 101-104.
[cited by applicant]
Fan, J et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis. Apr. 2001; 37(4): 820-31.
[cited by applicant]
Flaherty, K.R., et al. Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial PneumoniaAm J Respir Crit Care Med. Sep. 1, 2003; 168(5): 543-8.
[cited by applicant]
Flies DB and Chen L, The new B7s: playing a pivotal role in tumor immunity, (2007) J Immunother. 30 (3): 251-60.
[cited by applicant]
Francisco LM, et al., PD-L1 regulates the development, maintenance, and function of induced regulatory T cells, J. Exp. Med. 2009;206:3015-3029.
[cited by applicant]
Frazdottir et al., Airway branching morphogenesis in three dimensional culture, Respir Res. 2010; 11 : 162.
[cited by applicant]
Freeman et al., Protect the killer: CTLs need defenses against the tumor, (2002) Nat. Med. 8:787-9.
[cited by applicant]
Freeman GJ, et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to hegative regulation of lymphocyte activation, J. Exp. Med. 2000;192:1027-1034.
[cited by applicant]
Friedman, Fibrogenic cell reversion underlies fibrosis regression in liver, Proc Natl Acad Sci USA. Jun. 12, 2012; 109(24): 9230-1.
[cited by applicant]
Furka, General method for rapid synthesis of multicomponent peptide mixtures, Int. J. Pept. Prot. Res. 37:487-493 (1991).
[cited by applicant]
Gangadharan, B. et al. Murine gammaherpesvirus-induced fibrosis is associated with the development of alternatively activated macrophages. J Leukoc Biol. Jul. 2008; 84(1): 50-8.
[cited by applicant]
Gasse et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice, J Clin Invest. Dec. 2007; 1 17(12): 3786-99.
[cited by applicant]
Gasse, P., et al. IL-1 and IL-23 Mediate Early IL-17A Production in Pulmonary Inflammation Leading to Late Fibrosis. PLoS One. 2011; 6(8): e23185.
[cited by applicant]
Gates RE, et al., Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture, Cell Growth Differ. 1994;5(8):891-9.
[cited by applicant]
Giangreco et al., Molecular phenotype of airway side population cells, Am J Physiol Lung Cell Mol Physiol. 2004; 286: L624-30.
[cited by applicant]
Giannone, G., et al. Substrate rigidity and force define form through tyrosine phosphatase and kinase pathways. Trends Cell Biol. Apr. 2006; 16(4): 213-23.
[cited by applicant]
Gilmore AP, Romer LH., Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation, Mol Biol Cell. 1996;7(8):1209-24.
[cited by applicant]
Goldstein R., et al., Failure of mechanical properties to parallel changes in lung connective tissue composition in bleomycin-induced pulmonary fibrosis in hamsters, Am Rev Respir Dis., 120(1 ):67-73, 1979.
[cited by applicant]
Golubovskaya VM, at al., Focal adhesion kinase and p53 signaling in cancer cells, Int Rev Cytol. 2007;263:103-53.
[cited by applicant]
Grinnell & Harrington. Pulmonary endothelial cell interactions with the extracellular matrix. In: Voelkel NF, Rounds S, eds. The Pulmonary Endothelium: Function in Health and Disease. Chichester, West Suxssex: Wiley-Bla…
[cited by applicant]
Habif, Dermatologic surgical procedures. Clinic Dermatology: A Color Guide to Diagnosis and Therapy. 3rd ed. 1996. 809-810.
[cited by applicant]
Hagohara et al., Vinylogous Polypeptides: An Alternative Peptide Backbone, J. Amer. Chem. Soc. 114:6568 (1992).
[cited by applicant]
Harari & Caminati, IPF: new insight on pathogenesis and treatment, Allergy. May 2010; 65(5):537-53.
[cited by applicant]
Hashimoto et al., Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis, Am J Respir Cell Mol Biol. Aug. 2010; 43(2): 161-72.
[cited by applicant]
Hashimoto, N., et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest. Jan. 2004; 113(2): 243-52.
[cited by applicant]
Haxhinasto S, et al., The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells, J. Exp. Med. 2008;205:565-574.
[cited by applicant]
He et al., Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/?-catenin activity in CKD, J Am Soc Nephrol. Feb. 2012; 23(2): 294-304.
[cited by applicant]
Hecker L. et al., NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury, Nat. Med., 15(9): 1077-81, 2009.
[cited by applicant]
Hegab et al., Catalytic Combustion and NO Formation of Natural Gas, Stem Cells Dev. 2010; 19: 523-3.
[cited by applicant]
Henikoff & Henikoff , Amino acid substitution matrices from protein blocks, Proc. Natl. Acad. Sci. USA, 1989, 89 : 10915.
[cited by applicant]
Higgins and Sharp, CLUSTAL: A package for performing multiple sequence alignment on a microcomputer, Gene 73:237-244 (1988).
[cited by applicant]
Higgins and Sharp, Fast and sensitive multiple sequence alignments on a microcomputer, CABIOS 5: 151-153 (1989).
[cited by applicant]
Hinz et al., The myofibroblast: one function, multiple origins, Am J Pathol. Jun. 2007; 170(6): 1807-16.
[cited by applicant]
Hinz, B., Masters and servants of the force: The role of matrix adhesions in myofibroblast force perception and transmission. Eur J Cell Biol. Apr. 2006; 85(3-4): 175-181.
[cited by applicant]
Hinz, Formation and Function of the Myofibroblast during Tissue Repair, J Invest Dermatol. Mar. 2007; 127(3): 526-37.
[cited by applicant]
Hinz, Myofibroblast development is characterized by specific cell-cell adherens junctions, et al. Mol Biol Cell. Sep. 2004; 15(9): 4310-20.
[cited by applicant]
Hinz, The myofibroblast: one function, multiple origins et al., Am J Pathol. Jun. 2007; 170(6): 1807-16.
[cited by applicant]
Hirschmann et al., Nonpeptidal Peptidomimetics with a B-D-Glucose Scaffolding. A Partial Somatostatin Agonist Bearing a Close Structural Relationship to a Potent, Selective Substane P Antagonist, J. Amer. Chem. Soc. 114…
[cited by applicant]
Hobbs et al., “Diversomers”: an approach to nonpeptide, nonoligomeric chemical diversity, Proc. Nat. Acad. Sci. USA 90:6909-6913 (1993).
[cited by applicant]
Hoffman et al., Lung-Derived Mesenchymal Stromal Cell Post-Transplantation Survival, Persistence, Paracrine Expresion, and Repair of Elastase-Injured Lung, Stem Cells Dev. 2011 ; 20: 1779-92.
[cited by applicant]
Holford & Scheiner, Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models 19981, Clin. Pharmacokinet. 6: 429-453.
[cited by applicant]
Homet Moreno B, and Ribas A. Anti-programmed cell death protein-1/ligand-1 therapy in different cancers. Br J Cancer. 2015;112(9):1421-7.
[cited by applicant]
Horowitz et al., Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth facto…
[cited by applicant]
International Search Report and Written Opinion for PCT/US2016/053743 dated Jan. 26, 2017, 6 pages.
[cited by applicant]
International Preliminary Report on Patentability for PCT/US2016/053743 dated Mar. 27, 2018, 5 pages.
[cited by applicant]
EP 16849854.1 Extended Search Report dated Mar. 1, 2019, 8 pages.
[cited by applicant]
International Search Report and Written Opinion for PCT/US2016/053771 dated Feb. 17, 2017, 16 pages.
[cited by applicant]
International Preliminary Report on Patentability for PCT/US2016/053771 dated Mar. 27, 2018, 10 pages.
[cited by applicant]
International Search Report and Written Opinion for PCT/IB2016/056575 dated Jun. 16, 2017, 12 pages.
[cited by applicant]
International Preliminary Report on Patentability for PCT/IB2016/056575 dated Mar. 27, 2018, 8 pages.
[cited by applicant]
EP 16848258.6 Extended Search Report dated Mar. 21, 2019, 8 pages.
[cited by applicant]
EP 16848258.6 First Examination Report dated Nov. 19, 2020, 4 pages.
[cited by applicant]
EP 16848258.6 Second Examination Report dated Jul. 1, 2021, 4 pages.
[cited by applicant]
International Search Report and Written Opinion for PCT/US2018/054244 dated Feb. 22, 2019, 14 pages.
[cited by applicant]
International Preliminary Report on Patentability for PCT/US2018/054244 dated Apr. 8, 2020, 10 pages.
[cited by applicant]
Abe et al., Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites. J Immunol. 2001, vol. 15; 166(12): 7556-7562.
[cited by applicant]
Abrahams et al., The T-box Transcription Factor Tbx2: Its Role in Development and Possible Implication in Cancer, IUBMB Life, 2010, vol. 62(2), pp. 92-102.
[cited by applicant]
Abreu et al., Decreased expression of Toll-like receptor 4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide.…
[cited by applicant]
Acharya et al., Fibroblast migration is mediated by CD44-dependent TGF beta activation. J Cell Sci. May 1, 2008; 121(Pt 9): 1393-402.
[cited by applicant]
Ahn et al., A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the Development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode. Respir Res. Jun. 8, 2011; 12:7…
[cited by applicant]
Alder et al., Telomere dysfunction causes alveolar stem cell failure. Proc. Nall. Acad. Sci. USA 112, 5099-5104 (2015).
[cited by applicant]
Amin et al., Surfactant protein deficiency in familial interstitial lung disease. J. Pedialr. 139, 85-92 (2001).
[cited by applicant]
Armanios et al., Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis. N Engl J Med. Mar. 29, 2007; 356(13): 1317-26.
[cited by applicant]
Armstrong et al., Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 31, 241-245 (2004).
[cited by applicant]
Arora et al., Multiple Roles and Interactions of Tbx4 and Tbx5 in Development of the Respiratory System. PLos Genet. 2012; 8(8): e1002866.
[cited by applicant]
Astarita et al., Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol. Sep. 12, 2012; vol. 3: Article 283, 1-11.
[cited by applicant]
Baarsma et al., Activation ofWNT/b-Catenin Signaling in Pulmonary Fibroblasts by TGF-bl Is Increased in Chronic Obstructive Pulmonary Disease. PLoS One. 2011; 6(9): e25450.
[cited by applicant]
Balestrini et al., The mechanical memory of lung myofibroblastswz. Integr Biol (Camb ). Apr. 2012; 4(4): 410-21.
[cited by applicant]
Barkauskas et al., Type 2 Alveolar Cells are Stem Cells in Adulting, 2013, J Clin Inves., vol. 12397), pp. 3025-3026.
[cited by applicant]
Bartel, DP, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297 (2004).
[cited by applicant]
Berge et al., Pharmaceutical Salts, J Pharm Sci, 66: 1-19 (1977).
[cited by applicant]
Bergers et al., The role of pericytes in blood-vessel formation and maintenance. Neuro Oneal. Oct. 2005; 7(4): 152-64.
[cited by applicant]
Birck et al., Human TAF1128 and TAF1118 Interact through a Histone Fold Encoded by Atypical Evolutionary Conserved Motifs Also Found in the SPT3 Family Cell 94: 239-49 (1998).
[cited by applicant]
Birmingham et al., A Protocol for Designing siRNAs with High Functionality and Specificity, Nat. Protec. 2007, vol. 2(9), pp. 2068-2078.
[cited by applicant]
Bisserier et al., Lung-targeted SERCA2a Gene Therapy: From Discovery to Therapeutic Application in Bleomycin-Induced Pulmonary Fibrosis, J Cell ImmunoL 2:149-56 {2020).
[cited by applicant]
Bolanos et al., Role of Sonic Hedgehog in idiopathic pulmonary fibrosis, Am J Physiol Lung Cell Mol Physiol, 2012, vol. 303, pp. 978-990.
[cited by applicant]
Bolton et al., Changes in Clara Cell 10 kDa Protein (CC10)-positive Cell Distribution in Acute Lung Injury following Repeated Lipopolysaccharide Challenge in the Rat. Toxicol Pathol. Apr. 2008; 36(3): 440-8.
[cited by applicant]
Bournazos et al., Fey Receptor IIIb (CD16b) Polymorphisms are Associated with Susceptibility to Idiopathic Pulmonary Fibrosis. Lung, Dec. 2010; 188(6): 475-81.
[cited by applicant]
Brummelkamp et al., A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, vol. 296:550-553.
[cited by applicant]
Bucala et al., Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. rn94;lcl):11-al.
[cited by applicant]
Campbell et al., Calculation of the internal surface of a lung. Nature 17:117 (1952).
[cited by applicant]
Cao et al. Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates lbrosis, Nat Med, 22, 154-162 (2016).
[cited by applicant]
Cebra-Thomas et al., T-box gene products are required for mesenchymal induction of epithelial branching in the embryonic mouse lung, Dev Dyn, 2003;226(1):82-90.
[cited by applicant]
Chan et al. Antisense oligonucleotides: from design to therapeutic application. Clin. Exp. Pharmacol. Physiol. 33( 5-6): 533-40 (2006).
[cited by applicant]
Chang et al. GATHER: a systems approach to interpreting genomic signatures. Bioinformatics. 2006; 22(23): 2926-33.
[cited by applicant]
Chapman HA., Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol. 2011 ;73:413-435.
[cited by applicant]
Chapman et al., Integrin Integrin α6β4 identifies an adult distal lung epithelial population with regenerative potential in mice, J. Clin. Invest 121, 2855-2862 (2011).
[cited by applicant]
Checa et al., MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum Genet. Dec. 2008; 124(5): 465-72.
[cited by applicant]
Chen et al., Beta-Catenin Mediates Mechanically Regulated, Transforming Growth Factor-beta1-Induced Myofibroblast Differentiation of Aortic Valve Interstitial Cells. Arterioscler Thromb Vase Biol. Mar. 2011; 31(3): 590-…
[cited by applicant]
Chen et al., Airway epithelial progenitors are region specific and show differential responses to bleomycin-induced lung injury, Stem Cells 2012, 30, 1948-1960.
[cited by applicant]
Cherng et al., Alpha-Smooth Muscle Actin (α-SMA), J Am Sci. 2008: 4(4): 7-9.
[cited by applicant]
Chilosi et al., Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis , Respiratory Research, Biomed Central Ltd., London, GB, 2006, vol. 7(1), p. 95.
[cited by applicant]
Chung, KF, Cytokines as targets in chronic obstructive pulmonary disease, (2006) Curr. Drug Targets 7: 675-81.
[cited by applicant]
Clark et al. The genetics of neonatal respiratory disease. Semin Fetal Neonatal Med. Jun. 2005; 10(3): 271-82.
[cited by applicant]
Claverie et al., Information Enhancement Methods for Large Scale Sequence Analysis. Comput. Chem., H:191-201 (1993).
[cited by applicant]
Cronkhite et al., Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis. Am J Respir Grit Care Med. Oct. 1, 2008; 178(7): 729-37.
[cited by applicant]
Darby et al., a-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing Lab Invest. Jul. 1990; 63(1): 21-29.
[cited by applicant]
Degrendele et al., Requirement for CD44 in Activated T Cell Extravasation into an Inflammatory Site. Science. Oct. 24, 1997; 278(5338): 672-5.
[cited by applicant]
Desai et al., Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature, 2014, vol. 507, 190-194.
[cited by applicant]
Desmouliere et al., Apoptosis Mediates the Decrease in Cellularity during the Transition between Granulation 11″issue and Scar. Am J Pathol. Jan. 1995; 146(1): 56-66.
[cited by applicant]
Di Sabatino et al., Blockade of transforming growth factor beta upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa…
[cited by applicant]
DNAzymes Scientific Background. Stema Biologicals, GmbH & Co. KG, www.stema-biologicals.com. printed from internet Sep. 24, 2018.
[cited by applicant]
Duffield, J.S. Cellular and molecular mechanisms in kidney fibrosis. J Clin. Invest. Jun. 2014; 124(6): 2299-306.
[cited by applicant]
Eblaghie et al., Evidence that autocrine signaling through Bmpr1a regulates the proliferation, survival and morphogenetic behavior of distal lung epithelial cells. Dev Biol. 291, 67-82 { 2006).
[cited by applicant]
Fandino et al., GLP-1 receptor agonist ameliorates experimental lung fibrosis, Sci. Rep. 10:18091 {2020).
[cited by applicant]
Fernando et al., The T-box transcription factor Brachyury promotes epithelial mesenchymal transition in human Tumor cells. J Clin Invest. 2010;120(2):533-544.
[cited by applicant]
Foronjy et al. Structural emphysema does not correlate with lung compliance: lessons from the mouse smoking model. Exp Lung Res. 2005;31(6):547-562.
[cited by applicant]
Fox, C., Drug Delivery & Development. Reversing Idiopathic Pulmonary Fibrosis. http://www.dddmag.com/riews/2014/10/reversing-idiopathic-pulmonary-fibrosis, Oct. 15, 2014; downloaded from internet Aug. 15, 2018.
[cited by applicant]
Franzdottir et al., Airway branching morphogenesis in three dimensional culture. Respir Res. 2010; 11: 162.
[cited by applicant]
Friedler et al., Development of a Functional Backbone Cyclic Mimetic of the HIV-1 Tat Arginine-rich Motif. U. Biol. Chem., 2000, 275:23783-23789.
[cited by applicant]
Fujita et al., RNAi Therapeutic Platforms for Lung Diseases, Pharmaceuticals, 2013, vol. 6, 223-250.
[cited by applicant]
Fukata et al., Cox-2 is regulated by Toll-like receptor 4 (TLR4) signaling: role in proliferation and apoptosis in the ntestine, Gastroenterology 131, 862-877 {2006).
[cited by applicant]
Fukuda et al., Patterns of Pulmonary Structural Remodeling After Experimental Paraquat Toxicity Am J Pathol. mas Mar; 118(3): 452-75.
[cited by applicant]
Furuhashi et al., Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with diopathic pulmonary fibrosis. Respir Med. Aug. 2010; 104(8): 1204-10.
[cited by applicant]
Gangloff et al., The histone fold is a key structural motif of transcription factor TFIID. Trends Biochem. Sci. 26: 250-257 (2001).
[cited by applicant]
Garbuzenko et al., Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug, Pharm Res, 26:382-94 (2009).
[cited by applicant]
Garcia, C.K. Idiopathic pulmonary fibrosis: update on genetic discoveries. Proc. Am. Thorac., 2011, Soc. 8, pp. 158-162.
[cited by applicant]
Gilani et al., CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis, PLoS One, Jan. 2, 20109; 5(1): e8959.
[cited by applicant]
Gilbert, H.S. Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of rnyeloproliferative disease. Prog Clin Biol Res. 1984; 154: 3-17 (Abstract).
[cited by applicant]
Glaser et al., Tbx4 Interacts with the Short Stature Homeobox Gene Shox2 in Limb Development. Dev Dyn. 2014, vol. 243(5), pp. 629-639.
[cited by applicant]
Gomperts et al., Foxj1 regulates basal body anchoring to the cytoskeleton of ciliated pulmonary epithelial cells. U Cell Sci. Mar. 15, 2004; 117(Pt 8): 1329-37.
[cited by applicant]
Gonzalez et al., HT11-280, a biomarker specific to the apical plasma membrane of human lung alveolar type II cells, J. Histochem. Cytochem. 2010, vol. 58, 891-901.
[cited by applicant]
Goodman et al., The Pharmacological Basis of Therapeutics, Ed. Joel G. Hardman, Lee E. Limbird, Eds., 10th Ed., McGraw Hill, New York (2001), p. 25, 50.
[cited by applicant]
Greene et al., Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J. Mar. 2002; 19(3): 439-46.
[cited by applicant]
Grutz, G., New Insights into the molecular mechanism of interleukin-10 mediated immunosuppression. J. Leukocyte Biol. 2005, 77: 3-15.
[cited by applicant]
Gutbeir et al., RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice, Pulm. Pharmacol Ther. 2010, 23:334-44.
[cited by applicant]
Guzy et al., Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin. Am. J. Respir. Cell Mol. Biol. 52, 116-128 {2015).
[cited by applicant]
Hegab et al., Isolation and Characterization of Murine Multipotent Lung Stem Cells. Stem Cells Dev. 2010; 19: 523-36.
[cited by applicant]
Heise et al., Mechanical Stretch Induces Epithelial-Mesenchymal Transition in Alveolar Epithelia via Hyaluronan Activation of Innate Immunity, J Biol Chem. May 20, 2011; 286(20): 17435-44.
[cited by applicant]
Hinz, B., Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment offibrosis, Curr Rheumatol Rep, Apr. 2009; 11(2): 120-6.
[cited by applicant]
Hinz et al., Alpha-Smooth Muscle Actin Expression Upregulates Fibroblast Contractile Activity, Mal Biol Cell. Sep. 2001; 12(9): 2730-41.
[cited by applicant]
Hirano, T. et al., Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the L-6 family of cytokine receptors, Oncogene, 2000, vol. 19: 2548-56.
[cited by applicant]
Hodgson et al., ELMOD2 Is a Candidate Gene for Familial Idiopathic Pulmonary Fibrosis. Am J Hum Genet. 006 Jul. 79(1): 149-54.
[cited by applicant]
Hofer et al., Infection of mice with influenza A/WSN/33 (H1 N1) virus alters alveolar type II cell phenotype. Am. U. Physiol. Lung Cell. Mol. Physiol. 308, L628-L638 (2015).
[cited by applicant]
Hogan et al., Repair and regeneration of the respiratory system: complexity, plasticity and mechanisms of lung Mem cell function. Cell Stem Cell 15, 123-138 (2014).
[cited by applicant]
Holgate, ST., Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease, Cytokine, 2004, vol. 28: 152-57.
[cited by applicant]
Hoyles et al., An Essential Role for Resident Fibroblasts in Experimental Lung Fibrosis Is Defined by Lineage-Specific Deletion of High-Affinity Type II Transforming Growth Factor b Receptor. Am J Respir Grit Care Med. …
[cited by applicant]
Humbles et al., A Critical Role for Eosinophils in Allergic Airways Remodeling. Science. Sep. 17, 2004; 305 (5691): 1776-9.
[cited by applicant]
Humphreys et al., Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2010;176(1):85-97.
[cited by applicant]
Hutyrova et al., Interleukin-1 Gene Cluster Polymorphisms in Sarcoidosis and Idiopathic Pulmonary Fibrosis. Am J Respir Grit Care Med. Jan. 15, 2002; 165(2): 148-51.
[cited by applicant]
Iwaisako et al., Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci USA. Aug. 12, 2014; 111 32): E3297-305.
[cited by applicant]
Iwano et al., Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002; 110 3):341-350.
[cited by applicant]
Jakubzick et al. Impact of Interleukin-13 Responsiveness on the Synthetic and Proliferative Properties of Th1-2nd Th2-Type Pulmonary Granuloma Fibroblasts. Am J Pathol., 2003, 162(5): 1475-86.
[cited by applicant]
Jana et al., RNA Interference Potential Therapeutic Targets, Appl. Microbial. Biotechnol., 2004, vol. 65:649-657.
[cited by applicant]
Jeannotte et al., Unsuspected effects of a lung-specific Cre deleter mouse line, Genesis 49, 152-159 (2011).
[cited by applicant]
Jensen et al., Essentials of Recombinase-Based Genetic Fate Mapping in Mice, Methods Mol Biol. 2014; 1092: J37-54.
[cited by applicant]
Jensen et al., Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation, J. Control Release 142:138-45 (2010).
[cited by applicant]
Jiang et al., Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J. Clin. Invest 114, 291-299 (2004).
[cited by applicant]
Jiang et al., The role of Toll-like receptors in noninfectious lung injury. Cell Res. 16, 693-701 (2006).
[cited by applicant]
Jiang et al., Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 23, 435-461 (2007).
[cited by applicant]
Jiang et al., Inhibition of pulmonary fibrosis in mice by CXCL 10 requires glycosaminoglycan binding and syndecan 4, J. Clin. Invest 120, 2049-2057 (2010).
[cited by applicant]
Jiang et al., Hyaluronan as an Immune Regulator in Human Diseases. Physiol Rev. Jan. 2011; 91(1): 221-64.
[cited by applicant]
Jiang et al., Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling oathway in activation. J Hepatol. Sep. 2006; 45(3): 401-9.
[cited by applicant]
Jozefczuk et al., Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and nduced pluripotent stem cells, J Vis Exp, 2012;(64):3854.
[cited by applicant]
Kalai et al., Analysis of the Human Interleukin-6/Human Interleukin-6 Receptor Binding Interface at the Amino Acid Level: Proposed Mechanism of Interaction, Blood, 1997, 89:1319-33.
[cited by applicant]
Kalluri et al., Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. Dec. 2003; 112(12): H76-84.
[cited by applicant]
Kamari et al., Lack of Interleukin-1alpha or Interleukin-1beta Inhibits Transformation of Steatosis to Steatohepatitis and Liver Fibrosis in Hypercholesterolemic Mice. J Hepatol. Nov. 2011; 55(5): 1086-94.
[cited by applicant]
Kanasty et al., Delivery materials for siRNA therapeutics, 2013, Nat. Mater. 12:967-77.
[cited by applicant]
Kawai et al., Unresponsiveness of MyDBB-deficient mice to endotoxin. Immunity 11, 115-122 (1999).
[cited by applicant]
Keane et al., The importance of balanced pro-inflammatory and antiinflammatory mechanisms in diffuse lung Disease. Am J Physiol Lung Cell Mol Physiol. Jul. 2001; 281(1): L92-7.
[cited by applicant]
Kim, V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews, Molecular Cell Biology 6(5):376-385 (2005).
[cited by applicant]
Kolb et al., Transient expression of IL-1? induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest. Jun. 2001; 107(12): 1529-36.
[cited by applicant]
Komiya et al., Wnt signal transduction pathways. Organogenesis. Apr.-Jun. 2008; 4(2): 68-75.
[cited by applicant]
Korthagen et al., Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis. Respir Med.Jan. 2011; 105(1): 106-13.
[cited by applicant]
Kotton et al., Lung regeneration: mechanisms, applications and emerging stem cell Dopulations. Nat. Med. 20, 822-832 (2014).
[cited by applicant]
Kretzschmar et al., Lineage Tracing. Cell. Jan. 20, 2012; 148(1-2): 33-45.
[cited by applicant]
Kuan et al., Glycoprotein Nonmetastatic Melanoma Protein B, a Potential Molecular Therapeutic Target in Patients with Glioblastoma Multiforme. Clin. Cancer Res 12:(7) 1970-82 (2006).
[cited by applicant]
Kumar et al., Defining a mesenchymal progenitor niche at single cell resolution. Science. Nov. 14, 2014; 346(6211): 1258810.
[cited by applicant]
Laan et al., Neutrophil Recruitment by Human IL-17 via C-X-C Chemokine Release in the Airways. J Immunol. Feb. 15, 1999; 162(4): 2347-52.
[cited by applicant]
Lagares et al., Inhibition of Focal Adhesion Kinase Prevents Experimental Lung Fibrosis and Myofibroblast Formation. Arthritis Rheum, May 2012, vol. 64, No. 5. 1653-1664.
[cited by applicant]
Lagana et al., Synthetic RNAs for Gene Regulation: Design Principles and Computational Tools, 2014, Front. Bioeng. Biotechnol. 2:65.
[cited by applicant]
Lai et al., Comparison between the Repression Potency of siRNA Targeting the Coding Region and the 3′-Untranslated Region of mRNA, Biomed Res Int. 2013, vol. 2013:637850, pp. 1-5.
[cited by applicant]
Larrucea et al., Expression of podocalyxin enhances the adherence, migration, and intercellular communication Pf cells. Exptl Cell Res. 314: 2004-15 (2008).
[cited by applicant]
Larsson et al., Fibrotic Myofibroblasts Manifest Genome-Wide Derangements of Translational Control. PLoSOne. Sep. 16, 2008; 3(9): e3220.
[cited by applicant]
Lawrence, T., The Nuclear Factor NF-kB pathway in inflammation, Cold Spring Harbor Perspectives in Biol. (2009) 1 (6): a001651.
[cited by applicant]
Lawson et al., Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax. Nov. 2004; 59(11): 977-80.
[cited by applicant]
Le et al., Blockade of IL-6 Trans-Signaling Attenuates Pulmonary Fibrosis, J. Immunol., 2014, vol. 193, pp. 3755-3768.
[cited by applicant]
Lee et al., Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1 hrombospondin-1 axis. Cell 156, 440-455 (2014).
[cited by applicant]
Lesley et al., CD44 and Its Interaction with Extracellular Matrix. Adv Immunol. 1993; 54: 271-335.
[cited by applicant]
Levick, et al., Cardiac Mast Cells Mediate Left Ventricular Fibrosis in the Hypertensive Rat Heart. Hypertension. Jun. 2009; 53(6): 1041-1047.
[cited by applicant]
Levy et al., What does Stat3 do?, J. Clin. Invest. 2002, vol. 109(9): 1143-48.
[cited by applicant]
Lewis et al., Efficient delivery of siRNA for inhibition of gene expression in postnatal mice, Nature Genetics, 2002, vol. 32:107-108.
[cited by applicant]
Li et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J Exp Med. Jul. 4, 2011; 208(7): 1459-1471.
[cited by applicant]
Li et al., Transforming growth factor-betal induces EMT by the transactivation of epidermal grow1h factor signaling through HA/CD44 in lung and breast cancer cells, Int J Mol Med, 2015, vol. 36(1), pp. 113-122.
[cited by applicant]
Liang et al., NF-kappaB and its regulation on the immune system, Cell. Mol. Immunol. 2004, vol. 1(5): 343-50.
[cited by applicant]
Liang et al., Role of hyaluronan and hyaluronan-binding proteins in human asthma. J. Allergy Clin. Immunol., 2011, vol. 128, J03-411.e3.
[cited by applicant]
Liang et al., A macrophage subpopulation recruited by CC chemokine ligand 2 clears apoptotic cells in non- nfectious lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 302, L933-L940 (2012).
[cited by applicant]
Liang et al., MK2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis, Am J. Respir. Grit Care Med, 2015, vol. 191, A5333, Abstract only.
[cited by applicant]
Liang et al., Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice. Nat Med. 22 (11) :1285. Nov. 2016.
[cited by applicant]
Liang et al., Hyaluronan and TLR4 Regulate Alveolar Stem Cell Renewal and Prevent Severe PulmonaryFibrosis Gene Accession No. GSE68704 retrieved from https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc-GSE68704 on Apr. 1…
[cited by applicant]
Liu et al., miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. Aug. 2, 2010 207(8): 1589-97.
[cited by applicant]
Liu et al., Sonic hedgehog signaling directly targets Hyaluronic Acid Synthase 2, an essential regulator of ohalangeal joint patterning, Dev Biol. Mar. 15, 2013; 375(2): 160-71.
[cited by applicant]
Liu et al., Association of ENA-78, IP-10 and VEGF gene polymorphism with idiopathic pulmonary fibrosis. Zhonghuc vi xue za zhi. Oct. 20, 2009; 89(38): 2690-4 (Abstract).
[cited by applicant]
Liu et al., Activation of type II cells into regenerative stem-cell-antigen-1+ cells during alveolar repair. Am. J. Respir. Cell Mol. Biol. 53, 113-124 (2015).
[cited by applicant]
Livet et al., Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature, Nov. 1, 2007; 450: 56-62.
[cited by applicant]
Loberg et al., Enhanced Glycogen Synthase Kinase-3beta Activity Mediates Hypoxia-induced Apoptosis of Vascular Smooth Muscle Cells and Is Prevented by Glucose Transport and Metabolism. J. Biol. Chem. 277 (44): 41667-673…
[cited by applicant]
Lovgren et al., Beta-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix, Sci Transl Med, 2011, vol. 3. pp. 1-22.
[cited by applicant]
Lown et al., The mechanism of the bleomycin-induced cleavage of DNA1. Biochem Biophys Res Commun. 2977 Aug. 22; 77(4): 1150-7.
[cited by applicant]
Ma et al., Indian hedgehog mutations causing brachydactyly type Al impair Hedgehog signal transduction at multiple levels, Cell Res. 21: 1343-57 (2011).
[cited by applicant]
Madisen et al., A robust and high-throughput Cre reporting and characterization system for the whole mouse brain Nat Neurosci. Jan. 2010; 13(1): 133-40.
[cited by applicant]
Mailleuix et al., Fgf10 expression identifies parabronchial smooth muscle cell progenitors and is required for heir entry into the smooth muscle cell lineage, Development. May 2005; 132(9): 2157-66.
[cited by applicant]
Martinelli et al., A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset. Mol Biol Rep. Oct. 2011; 38(7): 4613-7.
[cited by applicant]
Martinez, E. Multi-protein complexes in eukaryotic gene transcription. Plant Mol. Biol. 50: 925-47 (2002).
[cited by applicant]
Martinez et al., The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014; 6:13.
[cited by applicant]
Matsumoto et al., Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb. Development 136, 2825-2835 (200…
[cited by applicant]
McGowan et al., Fibroblast growth factor signaling in myofibroblasts differs from lipofibroblasts during alveolar septation in mice, Am J Physiol Lung Cell Mol Physiol, 2015, vol. 309(5), pp. L463-L474.
[cited by applicant]
Meltzer et al., Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. BMC Med Genomics. Oct. 5, 2011; 4:70.
[cited by applicant]
Merkel et al., Nonviral siRNA Delivery to the Lung: Investigation of PEG-PEI Polyplexes and Their In Vivo Performance, Mol. Pharm, 6:1246-60 (2009).
[cited by applicant]
Mikecz et al., Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis, Nat Med. Jun. 1995; 1(6): 558-63.
[cited by applicant]
Minshall et al., Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma, Am J Respir Cell Mal boil. Sep. 1997; 17(3): 326-33.
[cited by applicant]
Moeller et al., Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. Apr. 1, 2009; 179(7): 588-94.
[cited by applicant]
Monroe et al., Platelets and Thrombin Generation. Arterioscler Thromb Vase Biol. 2002; 22:1381-1389.
[cited by applicant]
Moore et al., CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol. 2005; 166(3):675-684.
[cited by applicant]
Mummert et al., Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J. Exp. Med., 2000, 192, pp. 769-779.
[cited by applicant]
Murphy et al., Janeway's Immunology, 9th Ed. 2017, Garland Science, New York, Chapter 3, pp. 109-110.
[cited by applicant]
Mushiroda et al., A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet. Oct. 2008; 45(10): 654-6.
[cited by applicant]
Myers et al., Optimal alignments in linear space. Computer Applic. Biol. Sci., 4:11-17 (1988).
[cited by applicant]
Naiche et al., Identity and Fate of Tbx4-Expressing Cells Reveal Developmental Cell Fate Decisions in the Allantois, Limb, and External Genitalia. Dev Dyn, Oct. 2011; 240(10): 2290-300.
[cited by applicant]
Naito et al., siRNA Design Software for a Target Gene-Specific RNA Interference, 2012, Front. Genet. 3:102.
[cited by applicant]
Neal et al., Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53-upregulated modulator of apoptosis. J. Biol. Chem. 2012. 287, pp. 37296-37308.
[cited by applicant]
Nelson, AL, Antibody fragments, Mabs 2010, 2(1): 77-83.
[cited by applicant]
Ni et al., PD-1/PD-L 1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal StemCells in 3 Humanized Mice. American Journal of Respiratory Cell and Molecular Biology, 2018, vol. 58 (6):684-695.
[cited by applicant]
Noble et al., Hyaluronate Activation of CD44 Induces Insulin-like Growth Factor-1 Expression by a Tumor Necrosis Factor-alpha-dependent Mechanism in Murine Macrophages, J Clin Invest. Jun. 1993; 91 (6): 2368-77.
[cited by applicant]
Noble et al., Matrix regulation of lung injury, inflammation and repair: the role of innate immunity. Proc. Am. Thorac. 2006, Soc. 3, pp. 401-404.
[cited by applicant]
O'Donoghue et al., Genetic partitioning of interleukin-6 signaling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol. Med., 2012, vol. 4, pp. 939-951.
[cited by applicant]
Ogawa et al., Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun. Jan. 1, 2010; 391(1): 316-21.
[cited by applicant]
Oh et al., Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary nflammation and fibrosis in bleomycin-treated mice. J. Exp. Med., 2011, vol. 208, pp. 1707-1719.
[cited by applicant]
Ozerdem et al., NG2 Proteoglycan is Expressed Exclusively by Mural Cells During Vascular Morphogenesis. Dev Dyn, Oct. 2001; 222(2): 218-27.
[cited by applicant]
Paddison et al., Stable suppression of gene expression by RNAi in mammalian cells. PNAS 2002, vol. 99 (3):1443-1448.
[cited by applicant]
Pandit et al., Inhibition and role of let-7d in idiopathic pulmonary fibrosis, 2010, Am. J. Respir. Crit. Care Med. 182:220-29.
[cited by applicant]
Papaioannou, The T-box gene family: emerging roles in development, stem cells and cancer, Development, 2014, vol. 141, 3819-3833.
[cited by applicant]
Pardo et al., Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis. PLoS Med. Sep. 2005; 2(9): e251.
[cited by applicant]
Paul et al., Effective expression of small interfering RNA in human cells. Nature Biotechnology 2002. vol. 20 (5):505-508.
[cited by applicant]
Perl et al., Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis, Am. J. Pathol. 167:1545-59 (2005).
[cited by applicant]
Peterson et al., Prognostic Role of Eosinophils in Pulmonary Fibrosis. Chest. Jul. 1987; 92(1): 51-6.
[cited by applicant]
Piguet et al., Requirement of tumour necrosis factor for development of silica induced pulmonary fibrosis. Nature, Mar. 15, 1990; 344(6263): 245-7.
[cited by applicant]
Pivarcsi et al., Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int. Immunol. 2003, vol. 15, pp. 1721-1730.
[cited by applicant]
Pontoglio et al., Hepatocyte Nuclear Factor 1 Inactivation Results in Hepatic Dysfunction, Phenylketonuria, and Renal Fanconi Syndrome. Cell 84: 575-85 (1996).
[cited by applicant]
Rafii et al., Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration Nat. Cell Biol. 2015, vol. 17, pp. 123-136.
[cited by applicant]
Rakoff-Nahoum et al., Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis, Cell, 2004, vol. 118, 229-241.
[cited by applicant]
Rakoff-Nahoum et al., Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity, 2006, vol. 25, pp. 319-329.
[cited by applicant]
Rehan et al., PPAR? Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung. DPAR Res. vol. 2012; Article ID 289867, 8 pages 2012.
[cited by applicant]
Reiman et al., Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity. nfect Immun. Mar. 2006; 74(3): 1471-9.
[cited by applicant]
Richards et al., Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis.Am J Respir Grit Care Med. Jan. 1, 2012; 185(1): 67-76.
[cited by applicant]